Rapid Micro Biosystems, Inc. (RPID)
Largest Insider Buys in Sector
RPID Stock Price History Chart
RPID Stock Performance
About Rapid Micro Biosystems, Inc.
Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in North America, Europe, and Asia. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and comprehensive customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) …
Insider Activity of Rapid Micro Biosystems, Inc.
Over the last 12 months, insiders at Rapid Micro Biosystems, Inc. have bought $141,663 and sold $0 worth of Rapid Micro Biosystems, Inc. stock.
On average, over the past 5 years, insiders at Rapid Micro Biosystems, Inc. have bought $1.41M and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Kollender Richard S (director) — $50,128. Malloy Kirk (director) — $45,335. Spignesi Robert G. Jr. (PRESIDENT AND CEO) — $38,400.
The last purchase of 50,000 shares for transaction amount of $45,335 was made by Malloy Kirk (director) on 2024‑08‑08.
List of Insider Buy and Sell Transactions, Rapid Micro Biosystems, Inc.
| 2024-08-08 | director | 50,000 0.123% | $0.91 | $45,335 | +2.33% | |||
| 2024-08-07 | CHIEF FINANCIAL OFFICER | 10,000 0.0243% | $0.78 | $7,800 | +16.00% | |||
| 2024-08-06 | PRESIDENT AND CEO | 50,000 0.1147% | $0.77 | $38,400 | +11.40% | |||
| 2024-08-06 | director | 65,000 0.1497% | $0.77 | $50,128 | +11.40% | |||
| 2023-09-06 | CHIEF FINANCIAL OFFICER | 10,000 0.024% | $0.99 | $9,894 | -1.44% | |||
| 2023-08-15 | PRESIDENT AND CEO | 20,000 0.046% | $0.97 | $19,488 | -3.50% | |||
| 2023-08-08 | PRESIDENT AND CEO | 34,000 0.0817% | $0.92 | $31,447 | +5.98% | |||
| 2023-05-17 | PRESIDENT AND CEO | 20,000 0.0462% | $0.91 | $18,204 | +6.63% | |||
| 2022-06-02 | 20,602 0.0446% | $4.66 | $96,100 | -62.92% | ||||
| 2022-05-27 | 19,414 0.0406% | $4.76 | $92,407 | -58.50% | ||||
| 2022-05-25 | 12,396 0.0323% | $4.90 | $60,774 | -49.44% | ||||
| 2022-05-17 | 11,125 0.0243% | $3.94 | $43,861 | -43.29% | ||||
| 2022-05-16 | President and CEO | 10,000 0.0234% | $3.79 | $37,950 | -35.86% | |||
| 2022-03-10 | 10,000 0.0262% | $6.95 | $69,500 | -46.34% | ||||
| 2021-07-19 | 10 percent owner | 100,000 0.2804% | $20.00 | $2M | -59.26% | |||
| 2021-07-19 | 10 percent owner | 150,000 0.4205% | $20.00 | $3M | -59.26% |
Insider Historical Profitability
| Spignesi Robert G. Jr. | PRESIDENT AND CEO | 540012 1.2548% | $1.09 | 5 | 0 | <0.0001% |
| WIRTJES SEAN M | CHIEF FINANCIAL OFFICER | 348157 0.809% | $1.09 | 2 | 0 | |
| Kollender Richard S | director | 96718 0.2247% | $1.09 | 1 | 0 | |
| Malloy Kirk | director | 64300 0.1494% | $1.09 | 1 | 0 | |
| Bain Capital Life Sciences Investors, LLC | 10 percent owner | 8434560 19.5997% | $1.09 | 1 | 0 | <0.0001% |
Institutional Investor Ownership
| Bain Capital Life Sciences Investors Llc | $8.18M | 19.68 | 8.43M | 0% | +$0 | 0.66 | |
| Kennedy Lewis Management Lp | $4.79M | 11.53 | 4.94M | 0% | +$0 | 13.34 | |
| Glenview Capital Management | $1.28M | 3.08 | 1.32M | 0% | +$0 | 0.03 | |
| Abg Wtt Global Life Science Capital Partners Gp Ltd | $768,339.00 | 2.42 | 1.04M | 0% | +$0 | 1.85 | |
| BlackRock | $989,136.00 | 2.38 | 1.02M | -0.17% | -$1,677.13 | <0.0001 |